Anders P. Wiklund, M. Pharm.
Born in 1940. Chairman of the Board since 2017. Member of the Board since 2016. Member of the audit committee and the remuneration committee.
Education and relevant experience:
Pharmacist (MSc Pharm) from Farmaceutiska Institutet. He has also studied Business at Stockholm University. Anders P. Wiklund has more than 40 years of global experience in leading positions in pharmaceutical and biotechnology companies, inter alia as co-founder of Esperion and former President and CEO of KabiVitrum Inc and KabiPharmacia Inc.
Other current assignments:
Board member of EfRx Pharmaceuticals SA, Life Medical Sweden AB and Wiklund International AB. Member of the advisory board of Inspirion Drug Technologies LLC.
Shareholding in IRRAS: 13,182 shares
Holding of warrants: 100,000 warrants
Anders P Wiklund is independent in relation to the company and its management and in relation to major shareholders.